Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Hiccough

ondansetron has been researched along with Hiccough in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilkes, G1
Liaw, CC1
Wang, CH1
Chang, HK1
Liau, CT1
Yeh, KY1
Huang, JS1
Lin, YC1

Trials

1 trial available for ondansetron and Hiccough

ArticleYear
Gender discrepancy observed between chemotherapy-induced emesis and hiccups.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Chi-Square Distribut

2001

Other Studies

1 other study available for ondansetron and Hiccough

ArticleYear
Antiemetic agents.
    Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:8 Suppl

    Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipati

2007